A. Gulsvik (Bergen, Norway), C. Lai (Hong Kong, Hong Kong)
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece
N. M. Siafakas, (On Behalf of COPD Group) (Heraklion, Greece)
|  |
Underdiagnosis of COPD in hospitalized patients
T. Kamimura, Y. Oshita, T. Koga, Y. Sueyasu, M. Kinoshita, H. Aizawa (Kurume, Japan)
| |
Use of a 'COPD prevalence model' in two Italian general population samples
L. Carrozzi, M. Borbotti, A. Angino, F. Pistelli, S. Baldacci, A. Scognamiglio, G. Matteelli, F. Di Pede, G. Viegi (Pisa, Italy)
| |
Validation of the confronting COPD screening questionnaire in a respiratory clinic population
H. Muellerova, J. A. Wedzicha, J. B. Soriano, J. Vestbo (Greenford, London, United Kingdom; Copenhagen, Denmark)
| |
Use of quality of life measures and FEF25-75 to stratify GOLD stage I COPD into stage IA and stage IB
M. R. Maleki-Yazdi, C. K. Lewczuk, F. Kazim, J. M. Haddon, N. B. Choudry (Burlington, Canada)
| |
GOLDs definition of COPD in a Norwegian community by self-reported clinical diagnosis of obstructive lung disease and respiratory symptoms
S. Lehmann, S. E. Vollset, A. Gulsvik (Alesund, Bergen, Norway)
| |
Prevalence and severity of GOLD defined COPD in adults
A. Johannessen, P. S. Bakke, E. Omenaas, A. Gulsvik (Bergen, Norway)
| |
Impact of severity on three spirometric definitions of COPD
B. Schau, R. J. Halbert, B. R. Celli (Ingelheim, Germany; Santa Monica, Boston, United States Of America)
| |
Validation of non-spirometric predictors of COPD to the GOLD stage classification
M. R. Maleki-Yazdi, C. K. Lewczuk, F. Kazim, N. B. Choudry, J. M. Haddon (Mississauga, Canada)
| |
Early detection of COPD in mass spirometry
W. Lubinski, T. Plusa, J. M. Mierzejewska-Zawisza, R. Rozynska, S. From, T. Targowski, S. Dudko, A. Chcialowski (Warsaw, Poland)
| |
The proportion of non-symptomatic COPD is small
A. C. Jonsson, A. Lindberg, S. A. Jansson, M. Lindström, S. Andersson, L. G. Larsson, E. Rönmark, B. Lundbäck (Luleå, Stockholm, Sweden)
| |
How many young adults are at risk of COPD?
I. Cerveri, S. Accordini, A. Corsico, M. C. Zoia, P. Fulgoni, M. Beccaria, S. Colato, L. Carozzi, G. Viegi, R. de Marco (Pisa, Italy)
| |
The prevalence of airflow obstruction among a general population sample of 70-80 year olds in Northern Ireland; the NICECOP study
M. Magorrian, E. Murtagh, L. G. Heaney, J. Gingles, F. Kee, R. Shepherd, J. MacMahon (Belfast, United Kingdom)
| |
Evaluation of prevalence of COPD according to different criteria
A. Lindberg, L. G. Larsson, A. C. Jonsson, B. Lundbäck (Luleå, Stockholm, Sweden)
| |
Trends in hospitalization of patients with respiratory diseases in western Slovakia during 1992-2001
D. Magula, J. Plutinský, S. Petrcek (Nitra-Zobor, Slovakia)
| |
Lifetime costs of COPD in the Netherlands
T. L. Feenstra, M. P. M. H. Rutten-van Molken, M. M. L. van Genugten (Bilthoven, Rotterdam, The Netherlands)
| |
Costs of chronic obstructive pulmonary disease in Sweden
S. A. Jansson, A. Ericsson, E. Jönsson, S. Borg, E. Rönmark, F. Andersson, B. Lundbäck (Luleå, Umeå, Lund, Stockholm, Sweden)
| |
Chronic obstructive pulmonary disease (COPD) and medicine comsumption in Italian general population samples
M. Simoni, G. Matteelli, A. Angino, F. Pistelli, S. Baldacci, E. Polverino, L. Carrozzi, G. Viegi (Pisa, Italy)
| |
The cost of COPD: results from the SIRIBO study
L. G. Mantovani, S. Mannino, C. F. Donner, R. M. Busca, M. C. J. M. Sturkenboom (Milan, Segrate, Verona, Italy; Rotterdam, The Netherlands)
| |
A Markov model based on COPD disease severity to analyse the results from tiotropium trials
J. B. Oostenbrink, M. P. M. H. Rutten-van Molken, S. Anton, P. Koch (Rotterdam, The Netherlands; Ridgefield, United States Of America; Ingelheim, Germany)
| |